Interferon-Alpha Produces Sustained Cytogenetic Responses in Chronic Myelogenous Leukemia

Abstract

This study was the first to show sustained, complete cytogenetic responses in a subset of patients with chronic myelogenous leukemia treated with single-agent therapy. The nature of this remission, that is, whether it depends on continuous therapy, requires further study.